Xavier Pintó Selected Research

Xavier Pintó Research Topics

Disease

59	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 06/2002
41	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2024 - 01/2007
17	Dyslipidemias (Dyslipidemia) 07/2023 - 01/2007
17	Obesity 01/2023 - 03/2007
16	Type 2 Diabetes Mellitus (MODY) 07/2023 - 11/2012
16	Overweight 01/2023 - 01/2016
14	Hypertension (High Blood Pressure) 01/2023 - 01/2005
13	Hypercholesterolemia 01/2022 - 06/2005
12	Hypertriglyceridemia 02/2021 - 01/2007
10	Atherosclerosis 07/2023 - 01/2003
9	Myocardial Infarction 11/2020 - 03/2007
8	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 04/2024 - 03/2015
8	Arteriosclerosis 04/2024 - 03/2011
8	Body Weight (Weight, Body) 01/2024 - 05/2016
8	Weight Loss (Weight Reduction) 01/2024 - 11/2018
8	Abdominal Obesity 01/2023 - 01/2012
8	Stroke (Strokes) 11/2018 - 03/2007
6	Acute Coronary Syndrome 11/2020 - 07/2010
5	Inflammation (Inflammations) 08/2023 - 06/2002
5	Non-alcoholic Fatty Liver Disease 10/2022 - 11/2019
5	Cognitive Dysfunction 01/2022 - 01/2012
5	Insulin Resistance 01/2021 - 01/2007
5	Coronary Disease (Coronary Heart Disease) 01/2018 - 08/2004
4	Neoplasms (Cancer) 10/2021 - 01/2014
4	Hyperglycemia 01/2019 - 01/2007
4	Coronary Artery Disease (Coronary Atherosclerosis) 07/2016 - 05/2003
3	Chronic Disease (Chronic Diseases) 03/2024 - 05/2014
3	Prediabetic State (Prediabetes) 10/2022 - 01/2019
3	Peripheral Arterial Disease 10/2021 - 03/2007
3	Heart Diseases (Heart Disease) 10/2020 - 01/2016
3	Myocardial Ischemia (Ischemic Heart Diseases) 02/2020 - 01/2004
3	Fatty Liver 01/2020 - 05/2017
3	Diabetes Mellitus 11/2016 - 01/2007
3	Hyperlipidemias (Hyperlipidemia) 01/2007 - 06/2002
2	Carotid Artery Diseases 08/2023 - 01/2022
2	Rheumatoid Arthritis 08/2023 - 07/2009
2	Hyperuricemia 10/2022 - 08/2020
2	Weight Gain 01/2021 - 12/2018
2	Atherosclerotic Plaque (Atheroma) 12/2019 - 07/2016
2	Homozygous Familial Hypercholesterolemia 01/2019 - 07/2016
2	Heart Failure 01/2019 - 01/2017
2	Cataract (Cataracts) 05/2017 - 01/2017
2	Atrial Fibrillation 09/2015 - 07/2014

Drug/Important Bio-Agent (IBA)

32	LipidsIBA 07/2023 - 05/2003
23	Triglycerides (Triacylglycerol)IBA 01/2024 - 08/2004
22	LDL CholesterolIBA 04/2024 - 08/2004
21	HDL CholesterolIBA 01/2024 - 06/2002
18	Olive OilIBA 06/2021 - 01/2013
17	oxidized low density lipoproteinIBA 01/2024 - 01/2004
15	Lipoproteins (Lipoprotein)IBA 01/2024 - 06/2002
15	CholesterolIBA 07/2023 - 01/2004
15	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 03/2007
11	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2023 - 02/2006
8	LDL Lipoproteins (beta Lipoproteins)IBA 04/2024 - 08/2004
7	PolyphenolsIBA 10/2022 - 01/2014
7	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2011
7	Dietary Fats (Dietary Fat)IBA 11/2019 - 01/2013
6	HDL LipoproteinsIBA 08/2023 - 06/2002
5	Lipoprotein(a)IBA 04/2024 - 07/2009
5	AntioxidantsIBA 08/2023 - 01/2012
5	ApolipoproteinsIBA 12/2018 - 01/2007
5	Fibric Acids (Fibrates)IBA 07/2018 - 01/2007
4	EnzymesIBA 01/2023 - 01/2003
4	Proteins (Proteins, Gene)FDA Link 09/2022 - 02/2016
3	Apolipoproteins B (ApoB)IBA 07/2023 - 11/2018
3	Apolipoproteins E (ApoE)IBA 01/2022 - 09/2008
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2021 - 03/2019
3	Indicators and Reagents (Reagents)IBA 10/2021 - 10/2013
3	Folic Acid (Vitamin M)FDA LinkGeneric 03/2021 - 01/2005
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 08/2011
3	CarbohydratesIBA 01/2020 - 02/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2023 - 11/2020
2	Metformin (Glucophage)FDA LinkGeneric 05/2023 - 01/2021
2	Uric Acid (Urate)IBA 10/2022 - 08/2020
2	phenolic acidIBA 10/2022 - 08/2022
2	Vitamin K FDA Link 01/2022 - 05/2014
2	SugarsIBA 10/2021 - 01/2016
2	Caffeine (No Doz)FDA LinkGeneric 08/2021 - 01/2021
2	Coffee FDA Link 08/2021 - 01/2021
2	Ezetimibe (Zetia)FDA Link 05/2021 - 01/2008
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 01/2020
2	Monoclonal AntibodiesIBA 12/2019 - 01/2016
2	Apolipoprotein B-100 (Apo B 100)IBA 01/2019 - 01/2007
2	Proprotein Convertase 9IBA 01/2019 - 02/2016
2	LDL Receptors (LDL Receptor)IBA 11/2018 - 03/2015
2	Atorvastatin (Lipitor)FDA Link 01/2018 - 06/2002
2	Vitamin K 1 (Phylloquinone)FDA LinkGeneric 01/2017 - 05/2014
2	VLDL LipoproteinsIBA 11/2016 - 01/2007
2	Antihypertensive Agents (Antihypertensives)IBA 07/2015 - 08/2014
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2014 - 01/2003
2	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 11/2012 - 01/2012
2	C-Reactive ProteinIBA 01/2008 - 06/2002
2	HomocysteineIBA 08/2007 - 10/2006
2	Pravastatin (Pravachol)FDA LinkGeneric 06/2005 - 08/2004

Therapy/Procedure

48	Mediterranean Diet 01/2024 - 03/2010
9	Therapeutics 04/2023 - 06/2002
9	Secondary Prevention 10/2020 - 01/2004
3	Glycemic Control 01/2021 - 01/2019
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2021
2	Fat-Restricted Diet (Diet, Fat Restricted) 05/2017 - 11/2015